Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Cancers, Free Full-Text

Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches, Journal of Nanobiotechnology

Construction and characterization of mAb–Ang2 conjugates. (A)

Antibody-drug conjugates in lung cancer: dawn of a new era?

Molecular design and conjugation strategy for generating dual-drug

Primary brain tumours in adults - The Lancet

Simplified illustration of the mechanisms by which an antibody-drug

Antibody–drug conjugates come of age in oncology

Biomedicines, Free Full-Text

Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

JPM, Free Full-Text

Biomedicines, Free Full-Text

Full article: Antibody drug conjugates for glioblastoma: current progress towards clinical use

Unlocking the potential of antibody–drug conjugates for cancer therapy

MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain